Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, ...

today announced encouraging initial clinical data from the ongoing Phase I study of its lead compound THE001 in patients with heavily pre-treated, locally advanced unresectable or metastatic soft ...

In the dystopian world of the TV series, a heat-adapted version of the cordyceps fungus takes over humans, turning them into ...

Characterization of the lead compound, VU6007496, by our amazing DMPK team, provided important details on metabolite identification, species-specific metabolism, and the potential for undesired ...

CERo Therapeutics (CERO) announces the presentation of preclinical data demonstrating the capability of its lead compound CER-1236 to kill ...

They predicted that such compounds could be more effective against Cryptosporidium parasites and less toxic. The team identified two lead compounds that reduced the number of parasites in ...

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activity Data presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 ...